Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Jun;8(3):1915-1923.
doi: 10.1002/ehf2.13155. Epub 2021 Mar 10.

Resource utilization and costs among patients with heart failure with reduced ejection fraction following a worsening heart failure event

Affiliations
Observational Study

Resource utilization and costs among patients with heart failure with reduced ejection fraction following a worsening heart failure event

Michael M Givertz et al. ESC Heart Fail. 2021 Jun.

Abstract

Aims: The aim of this study is to characterize healthcare resource utilization and costs in patients with heart failure with reduced ejection fraction (HFrEF) following a worsening heart failure event.

Methods and results: This was a retrospective observational cohort analysis. Patients with HFrEF were identified from the PINNACLE Registry and linked to a nationwide pharmacy and medical claims database. Worsening heart failure was defined as stable heart failure with a subsequent hospitalization and/or intravenous diuretic therapy. Healthcare resource use and costs in 2015 US dollars were analysed for dispensed prescriptions, outpatient encounters, and hospital encounters. Among 11 064 patients with HFrEF, 3087 (27.9%) experienced a worsening heart failure event during an average follow-up of 973 days. During the first 30 days after the worsening event, 19.8% of patients had hospital readmissions with heart failure as the primary or secondary diagnosis. During that same time period, mean per patient heart failure-related healthcare resource use included 1.3 prescriptions, 0.5 practitioner visits, and 0.5 hospital encounters (admissions, observations, or emergency care), for an average total medical cost of $8779 per patient including $5359 in heart failure-related costs. During the first year following worsening heart failure onset, mean per patient total and heart failure-related costs were $62 615 and $35 329, respectively.

Conclusions: The economic burden following a worsening heart failure event calls for further review of methods to prevent progressive disease, improve adherence to guideline-directed therapy, and develop novel treatments and care strategies to moderate further progression.

Keywords: Cost and cost analysis/economics; Health resources; Heart failure/complications; Hospitalization.

PubMed Disclaimer

Conflict of interest statement

M. Givertz has research support from the National Institutes of Health and serves as a consultant to Merck. J. Butler has received research support from the National Institutes of Health, PCORI, and the European Union and serves as a consultant for Amgen, Array, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squib, CVRx, G3 Pharmaceutical, Innolife, Janssen, Luitpold, Medtronic, Merck, Novartis, Relypsa, StealthPeptide, SC Pharma, Vifor, and ZS Pharma. G. Hess was previously employed by Symphony Health, which received research support from Merck & Co. for the design and conduct of this study. G. Hess also conducts funded studies with governmental agencies, for example, the NIH, and professional societies, for example, the American College of Cardiology. M. Yang and B. Zhao are employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., and are shareholders of Merck & Co., Inc., Kenilworth, NJ, USA.

Figures

Figure 1
Figure 1
Study design. ED, emergency department; HFrEF, heart failure with reduced ejection fraction; IV, intravenous; LVEF, left ventricular ejection fraction.
Figure 2
Figure 2
Healthcare resource utilization per person per month following a worsening heart failure event for (A) prescriptions, (B) outpatient encounters, and (C) hospital encounters. The number of patients available at each time point were n = 3087 at 1 month, n = 2984 at 3 months, n = 2859 at 6 months, n = 2749 at 9 months, n = 2672 at 12 months, n = 1799 at 18 months, and n = 1277 at 24 months. Outpatient encounters include office and clinic visits. Hospital encounters include admissions, observational visits, and emergency department visits.
Figure 3
Figure 3
Total cumulative mean adjusted utilization costs following a worsening heart failure event. Costs are in US dollars, inflation‐adjusted for 2015.

References

    1. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, Ikonomidis JS, Khavjou O, Konstam MA, Maddox TM, Nichol G, Pham M, Pina IL, Trogdon JG, American Heart Association Advocacy Coordinating Committee , Council on Arteriosclerosis, Thrombosis and Vascular Biology , Council on Cardiovascular Radiology and Intervention , Council on Clinical Cardiology , Council on Epidemiology and Prevention , Stroke Council . Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 2013; 6: 606–619. - PMC - PubMed
    1. Hall MJ, Levant S, DeFrances CJ. Hospitalization for congestive heart failure: United States, 2000–2010. NCHS Data Brief 2012: 1–8. - PubMed
    1. Liao L, Allen LA, Whellan DJ. Economic burden of heart failure in the elderly. Pharmacoeconomics 2008; 26: 447–462. - PubMed
    1. Setoguchi S, Stevenson LW. Hospitalizations in patients with heart failure: who and why. J Am Coll Cardiol 2009; 54: 1703–1705. - PubMed
    1. Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J 2007; 154: 260–266. - PubMed

Publication types

LinkOut - more resources